Series A Funding Rounds: US Biotech VC Expectations 2026
In early 2026, US biotech VCs are intensely focused on Series A funding rounds for startups demonstrating groundbreaking scientific innovation, robust data, experienced teams, and clear paths to market, prioritizing high-impact therapeutic areas.
Future-Proof Your Biotech Career: Essential Certifications for 2026
To future-proof your career in the US biotech sector by 2026, focus on acquiring essential certifications in areas like bioinformatics, regulatory affairs, clinical trials, and biomanufacturing, enhancing your marketability and expertise.
Undervalued Small-Cap Biotech Stocks 2026: Beyond Big Pharma
This article delves into the exciting world of undervalued small-cap biotech stocks, offering practical solutions for investors seeking opportunities beyond the traditional big pharma landscape for 2026.
Choosing the Right US Biotech Event 2026: A Data-Driven Comparison
Choosing the right US biotech event in 2026 is crucial for industry professionals seeking to maximize networking, discover innovations, and forge strategic partnerships for business growth and scientific advancement.
US Biotech Startups: Securing CMO Deals for 2026 Production
US biotech startups are increasingly relying on strategic contract manufacturing organization (CMO) deals to ensure robust production capabilities for 2026, navigating complex regulatory landscapes and scaling efficiently for market entry.
Entry-Level Biotech Jobs US 2026: Expectation & Stand Out
The US entry-level biotech job market in 2026 is poised for growth, demanding specialized skills and strategic networking from candidates to navigate evolving industry trends and secure promising career paths.
Virtual vs. In-Person Biotech Events 2026: Maximizing Value
Delve into an in-depth analysis of virtual versus in-person US biotech events for 2026. This post examines key factors like networking, cost, accessibility, and content delivery to help you determine which event format provides superior value for your business objectives.
FDA Fast Track Designation 2026: Biotech Startup Guide to Accelerate Drug Approval
Navigate the complexities of FDA Fast Track Designation with this comprehensive 2026 guide. Biotech startups can learn how to expedite drug development, meet eligibility criteria, and strategically plan their application to shorten approval timelines.
AI’s Impact on US Biotech Recruitment: 4 Key Updates for Job Seekers
AI is rapidly reshaping US biotech recruitment. This article delves into four recent, critical updates impacting job seekers and employers, highlighting new skill demands, ethical considerations, and strategic shifts in talent acquisition within the biotech sector.
FDA Approvals & Biotech Stocks: 3-Month Valuation Analysis for US Investors
This article delves into the significant influence of recent FDA approvals on biotech stock valuations for US investors over a three-month period. We analyze market trends, highlight key approvals, and discuss strategic considerations for navigating this dynamic sector.